Evidence map›Paper›PMID 30626872›Full record

ArticleNature communications2019

Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase.

Anil K Padyana, Stefan Gross, Lei Jin, Giovanni Cianchetta, Rohini Narayanaswamy, Feng Wang, Rui Wang, Cheng Fang, Xiaobing Lv, Scott A Biller and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Squalene Epoxidase: Its Regulations and Links with Cancers.International journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Review
  4. Deciphering the genomic landscape ofMicrobial genomics · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Age-Associated Proteomic Changes in Human Spermatozoa.International journal of molecular sciences · 2025
    Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Anil K PadyanaAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA. anil.padyana@agios.com.ORCID http://orcid.org/0000-0001-5088-3401
Stefan GrossAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0003-4716-673X
Lei JinAgile Biostructure Solutions Consulting, LLC, 8 Harris Ave, Wellesley, MA, 02481, USA.
Giovanni CianchettaAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Rohini NarayanaswamyAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Feng WangWuxi Biortus Biosciences Co. Ltd., 6 Dongsheng West Road, Jiangyin, 214437, China.
Rui WangWuxi Biortus Biosciences Co. Ltd., 6 Dongsheng West Road, Jiangyin, 214437, China.
Cheng FangShanghai ChemPartner Co. Ltd., 998 Halei Road, 201203, Shanghai, China.
Xiaobing LvShanghai ChemPartner Co. Ltd., 998 Halei Road, 201203, Shanghai, China.
Scott A BillerAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Lenny DangAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Christopher E MahoneyAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0002-9480-5744
Nelamangala NagarajaAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
David PirmanAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Zhihua SuiAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Janeta Popovici-MullerAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.
Gromoslaw A SmolenAgios Pharmaceuticals, 88 Sidney Street, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0003-0136-4685
Agios Pharmaceuticals (United States) · USBiortus (China) · CNAgile Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Squalene epoxidase (SQLE), also known as squalene monooxygenase, catalyzes the stereospecific conversion of squalene to 2,3(S)-oxidosqualene, a key step in cholesterol biosynthesis. SQLE inhibition is targeted for the treatment of hypercholesteremia, cancer, and fungal infections. However, lack of structure-function understanding has hindered further progression of its inhibitors. We have determined the first three-dimensional high-resolution crystal structures of human SQLE catalytic domain with small molecule inhibitors (2.3 Å and 2.5 Å). Comparison with its unliganded state (3.0 Å) reveals conformational rearrangements upon inhibitor binding, thus allowing deeper interpretation of known structure-activity relationships. We use the human SQLE structure to further understand the specificity of terbinafine, an approved agent targeting fungal SQLE, and to provide the structural insights into terbinafine-resistant mutants encountered in the clinic. Collectively, these findings elucidate the structural basis for the specificity of the epoxidation reaction catalyzed by SQLE and enable further rational development of next-generation inhibitors.

Indexed as

AnimalsCatalytic DomainCell LineGene Expression Regulation, EnzymologicHumansInsectaProtein ConformationProtein DomainsSqualeneSqualene MonooxygenaseSqualeneSqualene Monooxygenase

Identifiers

PMID30626872
PMCPMC6327030
OpenAlexW2910712540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.